Trial Profile
Effects of voriconazole in patients with invasive fungal infections having different CYP2C19 genotype.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2015
Price :
$35
*
At a glance
- Drugs Voriconazole (Primary) ; Voriconazole (Primary)
- Indications Mycoses
- Focus Pharmacogenomic; Therapeutic Use
- 14 Jan 2015 New trial record